Biotechnology Halozyme Announces Commercial Launch of TLANDO(TM), an Oral Treatment for Testosterone Replacement Therapy June 7, 2022
Biotechnology Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon(TM) PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022 June 7, 2022
Biotechnology Apellis and Sobi Announce First Patient Dosed in Phase 3 VALIANT Study of Pegcetacoplan for IC-MPGN and C3G, Rare Kidney Diseases with High Unmet Medical Need June 7, 2022
Biotechnology Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer June 7, 2022
Biotechnology LAWSUITS FILED AGAINST IRNT, OSCR and AXSM – Jakubowitz Law Pursues Shareholders Claims June 6, 2022
Search
biotech investors
